Skip to content

Polyherbal steam inhalation versus Nasal Fumigation in children with rhinitis

Evaluation of Comparative Efficacy of Polyherbal Steam Inhalation versus Dhoopana (Polyherbal Nasal Fumigation) in children with Pratishyaya (Rhinitis): A Randomized Controlled Clinical Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050876
Enrollment
84
Registered
2023-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

None listed

Sponsors

Dr Monika
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from common cold, presenting with features of Pratishyaya (Rhinitis) for 7-10days.

Exclusion criteria

Exclusion criteria: Patients suffering from common cold for more than 10days. Patients with Chronic Allelrgic Rhinitis, Dushta Pratishyaya, Raktaja and Sannipataja Pratishyaya, Infectious diseases like T.B. Patients suffering from Cleft palate, DNS and Nasal Polyps. History of hypersensitivity to the trial drug or any of its ingredient.

Design outcomes

Primary

MeasureTime frame
1. To determine the efficacy of Dhoopana (Polyherbal nasal fumigation) in reducing sign and symptoms of Pratishyaya (Rhinitis) over that of Polyherbal steam inhalation. 2. Can be studied the duration of alleviation of TNSS (Total Nasal Symptom Score). 3. To determine the efficacy of Dhoopana (Polyherbal nasal fumigation) in reduction of nasal obstruction in Modified cold spatula test. Timepoint: At baseline, 3rd day, 5th day and 7th day.

Secondary

MeasureTime frame
Analysis of association between Prakriti and prevalence of Pratishyaya (Rhinitis) in children by using CCRAS Prakriti assessment questionnaire.Timepoint: At baseline, 3rd day, 5th day and 7th day.

Countries

India

Contacts

Public ContactDr Monika

Datta Meghe Institute of Medical Sciences, Sawangi (Meghe), Wardha (Maharashtra)

rbr.226@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026